Therefore, it is possible to hypothesize that molecular alterations in the cAMP/PKA or Wnt/beta catenin pathways might be involved in the pathogenesis of adrenocortical tumors, with the mechanisms underlying mHC being potentially different from those determining Cushing’s syndrome [55]. The gene discussed is CTNNB1; the disease is Cushing syndrome.